{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:14:22Z","timestamp":1777907662053,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1K23DK117055"],"award-info":[{"award-number":["1K23DK117055"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011284","name":"Valeant Pharmaceuticals International Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011284","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jhepr.2022.100478","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T13:27:25Z","timestamp":1648214845000},"page":"100478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis"],"prefix":"10.1016","volume":"4","author":[{"given":"Elliot B.","family":"Tapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Scott","family":"Winder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neehar D.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100478_bib1","article-title":"Incidence of and risk factors for hepatic encephalopathy in a population-based cohort of Americans with cirrhosis","author":"Tapper","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100478_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/thoraxjnl-2012-202374","article-title":"The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort","volume":"68","author":"Obiora","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jhepr.2022.100478_bib3","article-title":"Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis","volume":"1","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100478_bib4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cgh.2015.03.019","article-title":"Psychoactive medications increase the risk of falls and fall-related injuries in hospitalized patients with cirrhosis","volume":"13","author":"Tapper","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100478_bib5","article-title":"Appropriate and potentially inappropriate medication use in decompensated cirrhosis","author":"Thomson","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100478_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.04.012","article-title":"Falls are common, morbid, and predictable in patients with cirrhosis","author":"Tapper","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100478_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.jhepr.2022.100478_bib8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"Bmj"},{"key":"10.1016\/j.jhepr.2022.100478_bib9","article-title":"Deprescribing medications that may increase the risk of hepatic encephalopathy: a qualitative study of patients with cirrhosis and their doctors","author":"Williams","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhepr.2022.100478_bib10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhepr.2022.100478_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.jhepr.2022.100478_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhepr.2022.100478_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhepr.2022.100478_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1513\/AnnalsATS.201903-241OC","article-title":"Emulating a novel clinical trial using existing observational data. Predicting results of the PreVent study","volume":"16","author":"Admon","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jhepr.2022.100478_bib15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.jhepr.2022.100478_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.24616","article-title":"Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study","volume":"55","author":"Rakoski","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100478_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States","author":"Mellinger","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100478_bib18","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100478_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jhepr.2022.100478_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jhepr.2022.100478_bib21","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10620-013-3021-2","article-title":"Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience","volume":"59","author":"Lee","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2022.100478_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2018.01.026","article-title":"Increased morbidity and mortality associated with falls among patients with cirrhosis","author":"Ezaz","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.jhepr.2022.100478_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/gerona\/62.1.62","article-title":"Sleep disturbances and falls in older people","volume":"62","author":"Hill","year":"2007","journal-title":"Journals Gerontol Ser A: Biol Sci Med Sci"},{"key":"10.1016\/j.jhepr.2022.100478_bib24","article-title":"Frailty, psychoactive medications, and cognitive dysfunction are associated with poor patient-reported outcomes in cirrhosis","author":"Tapper","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100478_bib25","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000000762","article-title":"Incidence and bedside predictors of the first episode of overt hepatic encephalopathy in patients with cirrhosis","author":"Tapper","year":"2020","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"10.1016\/j.jhepr.2022.100478_bib26","first-page":"1","article-title":"Why do individuals with cirrhosis fall? A mechanistic model for fall assessment, treatment, and research","author":"Murphy","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2022.100478_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","article-title":"Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis","volume":"104","author":"Parr","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jhepr.2022.100478_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/apt.15749","article-title":"Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis","author":"Tapper","year":"2020","journal-title":"Aliment Pharmacol Ther"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:27:22Z","timestamp":1762900042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2589555922000507"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100478","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100478"}}